GlassScriptPhysician profile
Mary Elyse Veach
NPI 1992771398
$780.11
in general payments reported to CMS, 2019-2025
11 companies · $47.92 in 2025
The $47.92 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $75.00 · 2022: $139 · 2023: $299 · 2024: $220 · 2025: $47.92.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $566.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $566.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $232.82 | 2023-2025 | Veozah |
| Abbvie INC. | $180.39 | 2022-2023 | |
| Hologic Sales and Service, LLC | $84.44 | 2023 | Acessa Provu System, Coolseal Generator |
| Aspira Women'S Health INC | $75.00 | 2021 | |
| Organon LLC | $53.76 | 2024-2025 | Nexplanon, Nuvaring |
| Myriad Women'S Health, INC. | $37.91 | 2023 | Myrisk |
| Sumitomo Pharma America, INC. | $37.10 | 2024 | Myfembree, Gemtesa |
| Pacira Pharmaceuticals Incorporated | $28.45 | 2023 | Exparel |
| Medtronic, INC. | $17.88 | 2023 | Truclear |
| Daiichi Sankyo INC. | $16.48 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $15.88 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mary Veach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.